Börskollen
Pressmeddelanden från Lifecare
23 apr 10:58
LifecareMinutes from Annual General meeting 202601 apr 22:00LifecareAnnual General Meeting26 mar 15:02LifecareLifecare ASA – Operational restructuring to support transition to production and centralization of operations25 mar 13:49LifecareLifecare ASA: Share capital increase registered24 mar 07:00LifecareLifecare ASA Annual Report 202513 mar 23:37LifecareLifecare ASA: Mandatory notification of trade13 mar 20:03LifecareLifecare ASA - Chief Scientific Officer to step down from executive role13 mar 17:55LifecareLifecare ASA: Final results following expiry of exercise period for Warrants Series 1 issued in connection with Rights Issue13 mar 16:49LifecareLifecare ASA: Mandatory notification of trade13 mar 08:48LifecareLifecare ASA: Mandatory notification of trade13 mar 07:00LifecareLifecare ASA: Last day of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue12 mar 07:00LifecareEuropean Commission recognises Lifecare innovations in implantable glucose monitoring11 mar 15:29LifecareCorrection: Lifecare ASA: Mandatory notification of trade11 mar 14:28LifecareLifecare ASA: Mandatory notification of trade10 mar 13:38LifecareLifecare ASA: Mandatory notification of trade10 mar 08:15LifecareLifecare ASA: Mandatory notification of trade09 mar 22:34LifecareLifecare ASA receives regulatory feedback on first-in-human application, and has engaged Link Medical as advisor for a re-submission09 mar 13:09LifecareLifecare ASA: Mandatory notification of trade06 mar 14:14LifecareLifecare ASA: Mandatory notification of trade06 mar 09:01LifecareLifecare ASA: Mandatory notification of trade06 mar 07:00LifecareLifecare ASA: Last day of trading in Warrants Series 1 issued in connection with the Rights Issue05 mar 10:40LifecareLifecare ASA: Mandatory notification of trade05 mar 07:00LifecareLifecare confirms 12-week implant stability under real-life conditions – materially reduces durability risk ahead of first-in-human study03 mar 07:00LifecareLIFE: Lifecare ASA Q4 2025 results02 mar 07:00LifecareLifecare ASA: Commencement of the Exercise Period for Warrants Series 1 issued in connection with the Rights Issue27 feb 19:06LifecareLifecare ASA: Exercise price for Warrants Series 1 issued in connection with the Rights Issue26 feb 07:00LifecareLifecare reaches regulatory milestone - veterinary product cleared for sales in Europe25 feb 07:00LifecareLifecare ASA appoints Petter Nielsen as Chief Financial Officer24 feb 14:30LifecareLifecare ASA (LIFE): Invitation to Q4 2025 results presentation23 feb 07:00LifecareLifecare signs EU Declaration of Conformity for implant electronics19 feb 07:00LifecareLifecare receives notification of intended grant in European patent application and provides update on IP strategy17 feb 07:00LifecareLifecare completes production-level compliance testing of implant electronics - moves to finalize CE claim05 feb 07:56LifecareLifecare submits updated documentation to NoMA: regulatory review resumes in first-in-human study application03 feb 09:02LifecareLifecare ASA: Share capital increase and warrants registered30 jan 07:00LifecarePFU rules that Finansavisen breached press ethics in coverage of Lifecare’s market disclosures30 jan 07:00LifecareLifecare ASA: Information about the warrants issued in connection with the Rights Issue29 jan 17:04LifecareLifecare ASA: Mandatory notification of trade29 jan 14:45LifecareLifecare ASA: Mandatory notification of trade - allocation of Underwriting Commission Shares and Warrants29 jan 14:45LifecareLifecare ASA: Mandatory notification of trade - allocation of Underwriting Commission Shares and Warrants29 jan 13:55LifecareLifecare ASA: Resolution to issue underwriting commission shares28 jan 17:29LifecareLifecare ASA: Share capital increase and warrants registered23 jan 14:55LifecareLifecare ASA: Mandatory notification of trade22 jan 10:40LifecareLifecare ASA: Final results of the Rights Issue22 jan 10:12LifecareLifecare ASA: Mandatory notification of trade – subscription of shares in rights issue21 jan 20:16LifecareLifecare ASA: Preliminary results of the Rights Issue21 jan 07:00LifecareLifecare ASA: Last day of the subscription period for the Rights Issue19 jan 07:00LifecareLifecare highlights real-world veterinary relevance from ongoing diabetes study15 jan 07:00LifecareLifecare ASA: Last day of trading in Subscription Rights14 jan 14:05LifecareLifecare ASA: Mandatory notification of trade – subscription of shares in rights issue13 jan 07:00LifecareLifecare’s implant continues to track glucose where traditional CGMs reach their limits12 jan 11:00LifecareLifecare ASA (LIFE): Invitation to webcast presentation on 13 January 2026 at 11:30 CET08 jan 07:00LifecareLifecare confirms reproducible implant tracks glucose in vivo07 jan 09:44LifecareLifecare ASA: Mandatory notification of trade – allocation of subscription rights07 jan 07:00LifecareLifecare ASA: Commencement of the subscription period for the Rights Issue06 jan 10:52LifecareLifecare ASA: Approval and publication of prospectus for Rights Issue05 jan 22:38LifecareLifecare ASA – CFO transition05 jan 07:00LifecareLifecare ASA – Ex. subscription rights today02 jan 16:55LifecareLIFECARE ASA: Minutes from Extraordinary General Meeting31 dec 2025 10:40LifecareLifecare ASA: New share capital registered30 dec 2025 19:05LifecareLifecare ASA: Updated key information relating to the proposed partially underwritten rights issue16 dec 2025 07:00LifecareLifecare implants first consistently manufactured implant11 dec 2025 15:00LifecareLIFECARE ASA: Extraordinary General Meeting11 dec 2025 07:00LifecareLifecare receives preliminary assessment from NoMA in first-in-human study application12 nov 2025 20:34LifecareMinutes from Extraordinary General Meeting12 nov 2025 07:00LifecareLIFE: Lifecare ASA Q3 2025 results06 nov 2025 07:00LifecareLifecare ASA (LIFE): Invitation to presentation of Q3 2025 results05 nov 2025 07:00LifecareLifecare shares key learnings from ongoing longevity study LFC-SEN-00228 okt 2025 07:00LifecareLifecare receives update from NOMA on handling time for first-in-human study application22 okt 2025 14:00LifecareLIFECARE ASA: Extraordinary General Meeting22 okt 2025 07:16LifecareLifecare ASA: Key information relating to the proposed partially underwritten rights issue22 okt 2025 07:15LifecareLifecare ASA: Proposed partially underwritten rights issue24 sep 2025 07:00LifecareLifecare strengthens miniaturisation roadmap with new patent applications15 sep 2025 07:00LifecareLIFECARE RESUBMITS APPLICATION FOR FIRST-IN-HUMAN CLINICAL STUDY27 aug 2025 07:00LifecareReconfirmed positive results in veterinary study support path toward market entry20 aug 2025 07:00LifecareLIFE: Lifecare ASA Q2 2025 results13 aug 2025 07:47LifecareLifecare advances CE mark preparation for its groundbreaking medical device12 aug 2025 14:35LifecareLifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST05 aug 2025 07:00LifecareLifecare receives ethics approval to initiate first-in-human trial in Norway08 jul 2025 07:00LifecareLifecare achieves full radio frequency compliance for CGM implant – clearing the way for CE mark of electronics01 jul 2025 07:00LifecareLifecare advances electromagnetic compatibility compliance testing for CGM implant25 jun 2025 14:10LifecareLifecare ASA: Share capital increase registered13 jun 2025 18:19LifecareLifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue13 jun 2025 09:35LifecareLifecare ASA: Notification of trade - exercise of warrants13 jun 2025 07:00LifecareLifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue12 jun 2025 10:12LifecareLifecare ASA: Notification of trade - exercise of warrants12 jun 2025 10:11LifecareLifecare ASA: Notification of trade - exercise of warrants06 jun 2025 10:37LifecareLifecare ASA: Notification of trade - exercise of warrants06 jun 2025 07:00LifecareLifecare ASA: Last day of trading in the Warrants issued in connection with the Rights Issue05 jun 2025 12:52LifecareLifecare ASA: Mandatory notification of trade - exercise of warrants02 jun 2025 07:10LifecareLifecare ASA: Commencement of the Exercise Period for the Warrants issued in connection with the Rights Issue02 jun 2025 07:00LifecareLifecare ASA: Exercise price for the Warrants issued in connection with the Right Issue30 maj 2025 07:00LifecareLifecare announces second clinical trial site at Pfützner Science & Health Institute in Mainz, Germany27 maj 2025 07:00LifecareLifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial20 maj 2025 07:00LifecareLifecare files for human clinical trial, paving the way for CE-mark16 maj 2025 14:01LifecareLifecare ASA: Livestream strategic update15 maj 2025 07:00LifecareLIFE: Lifecare ASA Q1 202509 maj 2025 07:00LifecareLifecare ASA (LIFE): Invitation to presentation of Q1 2025 results and strategic update23 apr 2025 07:00LifecareLifecare ASA: Updated company presentation03 apr 2025 13:25LifecareAnnual General Meeting25 mar 2025 07:00LifecareLIFE: First positive indication of increased sensor sensitivity in ongoing longevity study
LifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecareLifecare